This Week in Cardiology cover image

Jul 7 2023 This Week in Cardiology

This Week in Cardiology

00:00

The Benefits of Dual Chamber Leadless Pacing

FDA has given approval to the first dual chamber leadless pacemaker. Technology is pretty amazing we shouldn't just glaze over it. Convince me help me not to be cynical about this. The primary safety endpoint was met at 90% of patients and they said that it met the safety performance goal of 78%. That too kind of makes me smile because who says a pacing procedure with up to a 22% bad event rate is a performance goal?

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app